Pharmaceutical and Biotechnology Industry Segment to Dominate Europe Metabolomics Services Market during 2021–2028

According to a new market research study on “Europe Metabolomics Services Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Application and Technology” is expected to reach US$ 484.02 million by 2028 from US$ 128.72 million in 2021. Rise in adoption of metabolomics and investments by the market players is the major factor driving the growth of the Europe metabolomics services market. However, issues associated with the high cost of tools, instruments, and usage hinder the growth of Europe metabolomics services market. The market is estimated to grow at a CAGR of 20.8% from 2021 to 2028. The report provides trends prevailing in the Europe metabolomics services market along with the drivers and restraints pertaining to the market growth.

The Europe metabolomics services market has been segmented based on service type, application, and country. On the basis of service type, the Europe metabolomics services market is segmented into targeted metabolomics service and untargeted metabolomics service. The targeted metabolomics service segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period. Based on application, the market is segmented into pharmaceutical and biotechnology industry, agritech, and environment. The pharmaceutical and biotechnology industry segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period. Likewise, the pharmaceutical and biotechnology industry segmented is categorized into biomarker discovery, drug discovery, toxicological testing, and others .Based on country, the metabolomics services market is classified into Germany, France, UK, Italy, Spain, and Rest of Europe.

The Europe metabolomics services market, based on service type, is segmented into targeted metabolomics service and untargeted metabolomics service. The targeted metabolomics service segment led the market in 2020. Targeted metabolomics is a quantitative method that involves the estimation of a group of metabolites with the help of 15N or 13C compounds. Various companies offer targeted metabolomics services. By quantifying the small molecules and comparing them against established standards, they can target metabolomics services to precisely observe the dynamic metabolic process, reveal appropriate metabolic mechanisms, and verify possible metabolic biomarkers. Utilizing state-of-the-art LC-MS/MS systems and techniques, metabolic service providers offer validated workflows of targeted metabolomics such as vitamins, amino acids, hormones, and many small molecules.

Afekta Technologies Ltd.; BASF SE; biocrates life sciences ag; Creative Proteomics; Fred Hutchinson Cancer Research Center; Metabolon, Inc.; metaSysX; MS-Omics; and RTI International are among the leading companies in the Europe metabolomics services market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2020, Creative Proteomics, an integrated contract research organisation (CRO) that offers a comprehensive spectrum of drug development services, has announced the debut of its fully developed untargeted metabolomics services to researchers.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com